VARESH PATEL: Open Payments
NPI 1760461289 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,097 in 134 payments from 29 companies in 2025. Trend: 2023 $1,817 · 2024 $4,168 · 2025 $3,097
Food & beverage: $3,097
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $458 |
| Axsome Therapeutics, Inc. | 7 | $266 |
| PFIZER INC. | 14 | $259 |
| Eisai Inc. | 13 | $221 |
| Braeburn Inc. | 11 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $168 |
| Dexcom, Inc. | 1 | $138 |
| Lilly USA, LLC | 7 | $135 |
| GlaxoSmithKline, LLC. | 6 | $133 |
| Lundbeck LLC | 5 | $122 |
Products named: REPATHA, Auvelity, Leqembi, REXULTI, NURTEC ODT, BRIXADI, Kerendia, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
